Published in Early Interv Psychiatry on January 24, 2013
Cognitive remediation in schizophrenia: current status and future perspectives. Schizophr Res Treatment (2013) 0.94
Early interventions in risk groups for schizophrenia: what are we waiting for? NPJ Schizophr (2016) 0.83
A systematic review on improving cognition in schizophrenia: which is the more commonly used type of training, practice or strategy learning? BMC Psychiatry (2014) 0.83
Enhancing Cognitive Training Through Aerobic Exercise After a First Schizophrenia Episode: Theoretical Conception and Pilot Study. Schizophr Bull (2016) 0.81
Neuroscience-informed Auditory Training in Schizophrenia: A Final Report of the Effects on Cognition and Serum Brain-Derived Neurotrophic Factor. Schizophr Res Cogn (2016) 0.81
The effects and determinants of exercise participation in first-episode psychosis: a qualitative study. BMC Psychiatry (2016) 0.80
The pro-cognitive mechanisms of physical exercise in people with schizophrenia. Br J Pharmacol (2017) 0.79
Age as a Moderator of Change Following Compensatory Cognitive Training in Individuals With Severe Mental Illnesses. Psychiatr Rehabil J (2016) 0.78
Neuropsychological and functional outcomes in recent-onset major depression, bipolar disorder and schizophrenia-spectrum disorders: a longitudinal cohort study. Transl Psychiatry (2015) 0.78
Cognitive remediation for adolescents with 22q11 deletion syndrome (22q11DS): a preliminary study examining effectiveness, feasibility, and fidelity of a hybrid strategy, remote and computer-based intervention. Schizophr Res (2015) 0.77
Intensive Auditory Cognitive Training Improves Verbal Memory in Adolescents and Young Adults at Clinical High Risk for Psychosis. Schizophr Bull (2016) 0.77
Early Detection of Psychosis: Recent Updates from Clinical High-Risk Research. Curr Behav Neurosci Rep (2015) 0.75
Age and Improved Attention Predict Work Attainment in Combined Compensatory Cognitive Training and Supported Employment for People With Severe Mental Illness. J Nerv Ment Dis (2016) 0.75
Cognitive remediation for adults with schizophrenia: Does age matter? Psychiatry Res (2016) 0.75
Model selection and prediction of outcomes in recent onset schizophrenia patients who undergo cognitive training. Schizophr Res Cogn (2017) 0.75
Optimizing psychosocial interventions in first-episode psychosis: current perspectives and future directions. Psychol Res Behav Manag (2017) 0.75
Neurocognitive effects of antipsychotic medications in patients with chronic schizophrenia in the CATIE Trial. Arch Gen Psychiatry (2007) 5.64
Determinants of real-world functional performance in schizophrenia subjects: correlations with cognition, functional capacity, and symptoms. Am J Psychiatry (2006) 4.77
White matter changes in schizophrenia: evidence for myelin-related dysfunction. Arch Gen Psychiatry (2003) 4.25
The Brief Assessment of Cognition in Schizophrenia: reliability, sensitivity, and comparison with a standard neurocognitive battery. Schizophr Res (2004) 3.57
Predicting schizophrenia patients' real-world behavior with specific neuropsychological and functional capacity measures. Biol Psychiatry (2007) 3.42
The effects of price on alcohol consumption and alcohol-related problems. Alcohol Res Health (2002) 3.37
An economic analysis of adult obesity: results from the Behavioral Risk Factor Surveillance System. J Health Econ (2004) 3.03
The Schizophrenia Cognition Rating Scale: an interview-based assessment and its relationship to cognition, real-world functioning, and functional capacity. Am J Psychiatry (2006) 2.95
Baseline neurocognitive deficits in the CATIE schizophrenia trial. Neuropsychopharmacology (2006) 2.70
Self-assessment of functional status in schizophrenia. J Psychiatr Res (2006) 2.65
Risperidone and haloperidol in first-episode psychosis: a long-term randomized trial. Am J Psychiatry (2005) 2.62
Assessment of community functioning in people with schizophrenia and other severe mental illnesses: a white paper based on an NIMH-sponsored workshop. Schizophr Bull (2006) 2.53
Characterizing affective instability in borderline personality disorder. Am J Psychiatry (2002) 2.44
Prediction of real-world functional disability in chronic mental disorders: a comparison of schizophrenia and bipolar disorder. Am J Psychiatry (2010) 2.35
The effects of hypertension and body mass index on cognition in schizophrenia. Am J Psychiatry (2010) 2.33
Neuropsychological impairments in schizophrenia: Integration of performance-based and brain imaging findings. Psychol Bull (2007) 2.25
Administration and interpretation of the Trail Making Test. Nat Protoc (2006) 2.18
Diffusion tensor imaging findings in first-episode and chronic schizophrenia patients. Am J Psychiatry (2008) 2.11
Characteristics of the MATRICS Consensus Cognitive Battery in a 29-site antipsychotic schizophrenia clinical trial. Schizophr Res (2010) 1.91
Evaluation of functionally meaningful measures for clinical trials of cognition enhancement in schizophrenia. Am J Psychiatry (2011) 1.86
Neuropsychological function and dysfunction in schizophrenia and psychotic affective disorders. Schizophr Bull (2008) 1.81
Is schizophrenia a syndrome of accelerated aging? Schizophr Bull (2007) 1.70
Usefulness of the UCSD performance-based skills assessment (UPSA) for predicting residential independence in patients with chronic schizophrenia. J Psychiatr Res (2007) 1.67
Determinants of everyday outcomes in schizophrenia: the influences of cognitive impairment, functional capacity, and symptoms. Schizophr Res (2009) 1.66
Cognition in schizophrenia: impairments, determinants, and functional importance. Psychiatr Clin North Am (2005) 1.63
A double blind placebo controlled trial of donepezil adjunctive treatment to risperidone for the cognitive impairment of schizophrenia. Biol Psychiatry (2002) 1.59
Cognitive impairment in schizophrenia. Handb Exp Pharmacol (2012) 1.57
Elaboration on premorbid intellectual performance in schizophrenia: premorbid intellectual decline and risk for schizophrenia. Arch Gen Psychiatry (2005) 1.55
First do no harm: managing antihistamine impairment in patients with allergic rhinitis. J Allergy Clin Immunol (2003) 1.55
Psychometric comparison of computerized and standard administration of the neurocognitive assessment instruments selected by the CATIE and MATRICS consortia among patients with schizophrenia. Schizophr Res (2007) 1.55
Validating measures of real-world outcome: the results of the VALERO expert survey and RAND panel. Schizophr Bull (2009) 1.54
Combined cognitive remediation and functional skills training for schizophrenia: effects on cognition, functional competence, and real-world behavior. Am J Psychiatry (2012) 1.53
Correlations of functional capacity and neuropsychological performance in older patients with schizophrenia: evidence for specificity of relationships? Schizophr Res (2006) 1.47
Effects of lithium on cognitive performance: a meta-analysis. J Clin Psychiatry (2009) 1.46
Neurocognitive impairment in bipolar disorder patients: functional implications. Bipolar Disord (2009) 1.46
Pharmacological treatment of cognition in schizophrenia: an idea whose method has come. Am J Psychiatry (2008) 1.44
Contemporary use of prasugrel in clinical practice: insights from the Blue Cross Blue Shield of Michigan Cardiovascular Consortium. Circ Cardiovasc Qual Outcomes (2013) 1.44
Assessing everyday functioning in schizophrenia: not all informants seem equally informative. Schizophr Res (2011) 1.37
Sensitivity of ICD-10 diagnosis of psychotic disorders in the Israeli National Hospitalization Registry compared with RDC diagnoses based on SADS-L. Compr Psychiatry (2005) 1.34
Norms and standardization of the Brief Assessment of Cognition in Schizophrenia (BACS). Schizophr Res (2008) 1.30
Does cytokine-induced depression differ from idiopathic major depression in medically healthy individuals? J Affect Disord (2009) 1.28
Functional implications of neuropsychological normality and symptom remission in older outpatients diagnosed with schizophrenia: A cross-sectional study. J Int Neuropsychol Soc (2008) 1.26
Social cognition in context: validating a cartoon-based attributional measure for urban girls. Child Dev (2006) 1.25
The relationship of the Brief Assessment of Cognition in Schizophrenia (BACS) to functional capacity and real-world functional outcome. J Clin Exp Neuropsychol (2006) 1.24
Neurocognitive assessment in the Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) project schizophrenia trial: development, methodology, and rationale. Schizophr Bull (2003) 1.24
Systemic hypotheses for generalized cognitive deficits in schizophrenia: a new take on an old problem. Schizophr Bull (2008) 1.21
Relationship of the Brief UCSD Performance-based Skills Assessment (UPSA-B) to multiple indicators of functioning in people with schizophrenia and bipolar disorder. Bipolar Disord (2010) 1.19
An initial evaluation of a culturally adapted social problem-solving and relational aggression prevention program for urban African-American relationally aggressive girls. J Prev Interv Community (2009) 1.17
Premorbid intellectual functioning and risk of schizophrenia and spectrum disorders. J Clin Exp Neuropsychol (2006) 1.17
Tuberculosis and immune thrombocytopenia. Haematologica (2002) 1.15
Memory performance in older trauma survivors: implications for the longitudinal course of PTSD. Ann N Y Acad Sci (2006) 1.14
Circumstances under which practice does not make perfect: a review of the practice effect literature in schizophrenia and its relevance to clinical treatment studies. Neuropsychopharmacology (2010) 1.13
Predictors of the accuracy of self assessment of everyday functioning in people with schizophrenia. Schizophr Res (2012) 1.12
Context-processing deficits in schizotypal personality disorder. J Abnorm Psychol (2004) 1.12
Relationship between premorbid functioning and symptom severity as assessed at first episode of psychosis. Am J Psychiatry (2002) 1.12
RISKS AND PRICES: THE ROLE OF USER SANCTIONS IN MARIJUANA MARKETS. B E J Econom Anal Policy (2010) 1.12
Fishing-related ocular trauma. Am J Ophthalmol (2005) 1.11
Sensitivity and specificity of the UCSD Performance-based Skills Assessment (UPSA-B) for identifying functional milestones in schizophrenia. Schizophr Res (2011) 1.11
Cognitive deficits and functional outcome in schizophrenia. Neuropsychiatr Dis Treat (2006) 1.11
Psychometric properties of performance-based measurements of functional capacity: test-retest reliability, practice effects, and potential sensitivity to change. Schizophr Res (2010) 1.09
Meta-analysis of the association between cognitive abilities and everyday functioning in bipolar disorder. Bipolar Disord (2012) 1.08
Dysregulation of X-linked gene expression in Klinefelter's syndrome and association with verbal cognition. Am J Med Genet B Neuropsychiatr Genet (2007) 1.07
Context processing in schizotypal personality disorder: evidence of specificity of impairment to the schizophrenia spectrum. J Abnorm Psychol (2008) 1.07
Modeling variability of force during isometric contractions of the quadriceps femoris. J Mot Behav (2002) 1.05
Premorbid functioning and treatment response in recent-onset schizophrenia. Br J Psychiatry (2006) 1.04
Premorbid intra-individual variability in intellectual performance and risk for schizophrenia: a population-based study. Schizophr Res (2006) 1.04
Memory performance in Holocaust survivors with posttraumatic stress disorder. Am J Psychiatry (2002) 1.02
The effects of child abuse and neglect on cognitive functioning in adulthood. J Psychiatr Res (2012) 1.01
Longitudinal assessment of cognitive performance in Holocaust survivors with and without PTSD. Biol Psychiatry (2006) 1.01
Postoperative cognitive dysfunction in patients with preoperative cognitive impairment: which domains are most vulnerable? Anesthesiology (2007) 1.00
Correlates of change in functional status of institutionalized geriatric schizophrenic patients: focus on medical comorbidity. Am J Psychiatry (2002) 1.00
Performance-based assessment of functional skills in severe mental illness: results of a large-scale study in China. J Psychiatr Res (2011) 1.00
Hippocampal volume in aging combat veterans with and without post-traumatic stress disorder: relation to risk and resilience factors. J Psychiatr Res (2006) 0.99
Development and psychometric performance of the schizophrenia objective functioning instrument: an interviewer administered measure of function. Schizophr Res (2008) 0.99
Age-associated differences in cognitive performance in older patients with schizophrenia: a comparison with healthy older adults. Am J Geriatr Psychiatry (2012) 0.98
Age-associated differences in cognitive performance in older community dwelling schizophrenia patients: differential sensitivity of clinical neuropsychological and experimental information processing tests. Schizophr Res (2007) 0.96
Relationship between cortisol and age-related memory impairments in Holocaust survivors with PTSD. Psychoneuroendocrinology (2005) 0.96
The effect of cigarette excise taxes on smoking before, during and after pregnancy. J Health Econ (2003) 0.96
The effects of guanfacine on context processing abnormalities in schizotypal personality disorder. Biol Psychiatry (2006) 0.95
Factor structure of the MATRICS Consensus Cognitive Battery (MCCB) in schizophrenia. Schizophr Res (2013) 0.95
Depression in schizophrenia: methodological artifact or distinct feature of the illness? J Neuropsychiatry Clin Neurosci (2008) 0.93
The relationship of neuropsychological test performance with the PANSS in antipsychotic naïve, first-episode psychosis patients. Schizophr Res (2004) 0.93
The relationship between symptomatic remission and neuropsychological improvement in schizophrenia patients switched to treatment with ziprasidone. Schizophr Res (2007) 0.93
Neurocognition, symptomatology, and functional skills in older alcohol-abusing schizophrenia patients. Schizophr Bull (2005) 0.93
Factors associated with functional recovery in bipolar disorder patients. Bipolar Disord (2010) 0.92
Depressed mood and its functional correlates in institutionalized schizophrenia patients. Schizophr Res (2005) 0.91
Dispositional impulsivity in normal and abnormal samples. J Psychiatr Res (2006) 0.91
Temporal characteristics of tract-specific anisotropy abnormalities in schizophrenia. Neuroreport (2008) 0.91
Learning and memory in Holocaust survivors with posttraumatic stress disorder. Biol Psychiatry (2004) 0.91
Communication abnormalities predict functional outcomes in chronic schizophrenia: differential associations with social and adaptive functions. Schizophr Res (2008) 0.91
Learning and memory in aging combat veterans with PTSD. J Clin Exp Neuropsychol (2005) 0.90
Social competence and observer-rated social functioning in bipolar disorder. Bipolar Disord (2010) 0.90
Convergence of different versions of the continuous performance test: clinical and scientific implications. J Clin Exp Neuropsychol (2003) 0.89
The longitudinal course of thought disorder in geriatric patients with chronic schizophrenia. Am J Psychiatry (2005) 0.89
Neuropsychological and symptom predictors of aggression on the psychiatric inpatient service. J Clin Exp Neuropsychol (2008) 0.89
Memory for trauma-related information in Holocaust survivors with PTSD. Psychiatry Res (2003) 0.89
Cognitive functioning predicts outpatient service utilization in schizophrenia. Ment Health Serv Res (2004) 0.89
Pergolide treatment of cognitive deficits associated with schizotypal personality disorder: continued evidence of the importance of the dopamine system in the schizophrenia spectrum. Neuropsychopharmacology (2010) 0.89
Cortical neuritic plaques and hippocampal neurofibrillary tangles are related to dementia severity in elderly schizophrenia patients. Schizophr Res (2010) 0.89
A post hoc analysis of negative symptoms and psychosocial function in patients with schizophrenia: a 40-week randomized, double-blind study of ziprasidone versus haloperidol followed by a 3-year double-blind extension trial. J Clin Psychopharmacol (2010) 0.88